Regulation of Focal Adhesion Kinase through a Direct Interaction with an Endogenous Inhibitor

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Focal adhesion kinase (FAK) is crucial for integrin and growth factor signaling.
• FAK-related non-kinase (FRNK) is an endogenous FAK inhibitor, sharing structural similarity.
• The role of FRNK phosphorylation at S217, the equivalent of FAK's S910, was previously unknown.

Purpose of the Study:

• To investigate the role of FRNK S217 phosphorylation in regulating FRNK's inhibitory activity.
• To elucidate the mechanism by which FRNK inhibits FAK activity.
• To understand FRNK's impact on smooth muscle cell signaling and apoptosis.

Main Methods:

• Utilized cultured rat aortic smooth muscle cells.
• Employed site-directed mutagenesis to create non-phosphorylatable FRNK (S217A).
• Assessed FAK autophosphorylation, protein-protein interactions, and smooth muscle cell apoptosis.

Main Results:

• ERK phosphorylates FRNK at S217 in smooth muscle cells.
• Mutation of S217 to alanine (S217A) created a 'superinhibitory' FRNK.
• S217A-FRNK strongly inhibited FAK autophosphorylation (Y397) and induced apoptosis.
• FRNK directly binds FAK, with this interaction enhanced by S217A mutation, rather than displacing FAK.

Conclusions:

• FRNK directly inhibits FAK activity by forming a complex.
• Phosphorylation of FRNK at S217 by ERK relieves this inhibition.
• FRNK regulates cell growth and survival pathways through direct interaction with FAK, modulated by S217 phosphorylation.